Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


UCL Professor wins 2013 Lloyd's Science of Risk Prize

9 December 2013

Helene Joffe, Professor of Psychology at the UCL Research Department of Clinical, Educational and Health Psychology, has won the 2013 Lloyd's Science of Risk Prize for her paper, Social Representations of Earthquakes: A Study of People Living in Three Highly Seismic Areas. 

The Lloyd's website has further information about the prize and the full list of winners and runners.